반응식
[F:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[CH:7][C:8](=[O:32])[N:9]2[CH2:12][CH2:13][N:14]2[CH2:19][CH2:18][CH:17]([NH:20][CH2:21][C:22]3[CH:26]=[C:25]([C:27]4[S:28][CH:29]=[CH:30][CH:31]=4)[O:24][N:23]=3)[CH2:16][CH2:15]2)=[CH:4][CH:3]=1.[ClH:33].C(OCC)(=O)C>C(Cl)(Cl)Cl>[ClH:33].[F:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[CH:7][C:8](=[O:32])[N:9]2[CH2:12][CH2:13][N:14]2[CH2:15][CH2:16][CH:17]([NH:20][CH2:21][C:22]3[CH:26]=[C:25]([C:27]4[S:28][CH:29]=[CH:30][CH:31]=4)[O:24][N:23]=3)[CH2:18][CH2:19]2)=[CH:4][CH:3]=1참가 물질
4
실험 절차
To 10 mL of a chloroform solution containing 232 mg of 7-fluoro-1-(2-(4-((5-(thiophen-2-yl)isoxazol-3-yl)methylamino)piperidin-1-yl)ethyl)quinoxalin-2(1H)-one, 1 mL of 4 mol/L hydrogen chloride/ethyl acetate was added, and stirred at room temperature for 10 min. The solvent was removed under reduced pressure, ethyl acetate was added, and the resulting solid was filtered to give 247 mg of 7-fluoro-1-(2-(4-((5-(thiophen-2-yl)isoxazol-3-yl)methylamino)piperidin-1-yl)ethyl)quinoxalin-2(1H)-one hydrochloride as a pale brown solid.
후처리
- additionwas added
- customThe solvent was removed under reduced pressure, ethyl acetate
- additionwas added
- filtrationthe resulting solid was filtered
출처 및 근거
- ORD 기록
- ord-d60dc14f45124801bd87704b1f769f3b
- 출처 데이터셋
- uspto-grants-2012_12
- 특허 번호
- US08329694B2
연결된 노트
불러오는 중…